SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 103.34 |
Enterprise Value ($M) | 224.89 |
Book Value ($M) | -172.94 |
Book Value / Share | -1.43 |
Price / Book | -0.60 |
NCAV ($M) | -227.47 |
NCAV / Share | -1.88 |
Price / NCAV | -0.45 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -1.33 |
Return on Equity (ROE) | -10.32 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.17 |
Current Ratio | 0.19 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 46.78 |
Assets | 101.31 |
Liabilities | 274.25 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 46.74 |
Operating Income | -105.43 |
Net Income | -114.33 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -20.71 |
Cash from Investing | -0.33 |
Cash from Financing | 23.58 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | SCLX Stock Acquisition JV LLC | 33.30 | 0.00 | |
13D/A | Sorrento Therapeutics, Inc. | 1.30 | -97.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
178,451 | 562,306 | 31.74 | |
196,796 | 228,870 | 85.99 | |
74,399 | 183,207 | 40.61 | |
95,124 | 148,568 | 64.03 | |
(click for more detail) |
Similar Companies | |
---|---|
SABS – SAB Biotherapeutics, Inc. | SAVA – Cassava Sciences, Inc. |
SBFM – Sunshine Biopharma, Inc. | SEEL – Seelos Therapeutics, Inc. |
SHPH – Shuttle Pharmaceuticals Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io